Latest Organofluorides Stories
NEW YORK, Oct.
Sales of Breast Cancer Therapies are Expected to Almost Double Through 2023, Fueled by Growth in Several Distinct Market Segments, According to Findings from Decision Resources Group BURLINGTON,
NORTHBROOK, Ill., Oct.
- Product strengthens growing antiretroviral franchise in the U.S. - PITTSBURGH, Oct. 3, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S.
DuPont Distribution Spans United States and Reaches 40 Countries in Europe, Middle-East and Africa WILMINGTON, Del., Oct. 6, 2014 /PRNewswire/ -- Kathryn K.
According to a new study, SSRIs can alter the brain’s architecture within hours, even though most patients don’t notice the effects until weeks of use.
A meta-analysis of published and unpublished clinical trial data, which was published in the journal PLOS ONE on Aug.
- LUX-Lung 8 trial met its primary endpoint of improving progression-free survival in patients treated with afatinib versus erlotinib after failure of first-line, platinum-based chemotherapy, reducing
The Firm is representing numerous clients in Risperdal lawsuits that allege the use of the antipsychotic medication caused gynecomastia (male breast growth). New
The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes allegedly due to their use of the statin medication. New
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.